February 26, 2007
Local (JPN)

For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshio Takahashi, Corporate Officer in Charge,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.co.jp/

Sankyo to Transfer All Shares of MEGURO CHEMICAL INDUSTRY

Sankyo Co., Ltd. of Daiichi Sankyo Group (President: Yasuhiro Ikegami, hereafter "Sankyo") and ROHTO Pharmaceutical Co., Ltd. (President: Kunio Yamada; hereafter "ROHTO") have agreed to transfer to ROHTO all shares of MEGURO CHEMICAL INDUSTRY COMPANY LIMITED (President: Takashi Katayama; hereafter "MEGURO"), a subsidiary of Sankyo.

 

MEGURO will develop their business for further growth in future as a wholly-owned subsidiary of ROHTO.

 

The effect that this share transfer will have on Daiichi Sankyo's business performance after the fiscal year ended March 2007 will be disclosed at a later date.

 

 

 

1. Planned Dates of Share Transfer  
  Conclusion of Share Transfer Agreement February 26, 2007
  Share Transfer March 22, 2007
2. Outline of the Companies Involved
  (1) MEGURO CHEMICAL INDUSTRY COMPANY LIMITED
Location of Head Office: 2-17-17 Meguro Honcho, Meguro-ku Tokyo
Date Established: July 21, 1954
Representative: Takashi Katayama
Capital: 40 million yen
Sales: 3,533 million yen (Fiscal year ended March 2006)
Number of Employees: 282(as of February 2007)
Major Businesses: Contracted manufacture of pharmaceutical products, quasi-drugs, cosmetics, health foods and others
     
  (2) ROHTO Pharmaceutical Co., Ltd.
Location: 1-8-1 Tatsumi-nishi, Ikuno-ku, Osaka
Date Established: September 15, 1949 (Originally founded: February 22, 1899)
Representative: Kunio Yamada
Capital: 5,409 million yen
Sales: 85,854 million yen (On a consolidated basis, Fiscal year ended March 2006)
Number of Employees: 2,265 (On a consolidated basis, Fiscal year ended March 2006)
Major Businesses: Manufacture and marketing of pharmaceutical products, cosmetics and functional foods
End